Literature DB >> 4786438

The management of malignant pleural effusion.

M L Sutton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4786438      PMCID: PMC2495806          DOI: 10.1136/pgmj.49.576.729

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  SIMPLIFIED MANAGEMENT OF MALIGNANT PLEURAL EFFUSION.

Authors:  D L KINSEY; D CARTER; K P KLASSEN
Journal:  Arch Surg       Date:  1964-08

2.  Malignant effusions treated by colloidal radioactive yttrium silicate.

Authors:  J WALTER
Journal:  Br Med J       Date:  1960-10-29

3.  Nitrogen mustard in palliation of mslignant effusions.

Authors:  V B LEVISON
Journal:  Br Med J       Date:  1961-04-22

4.  Radioactive colloidal gold in the treatment of pleural and peritoneal effusions of malignant origin: review of 235 cases.

Authors:  N MACKAY
Journal:  Lancet       Date:  1957-10-19       Impact factor: 79.321

5.  Studies on the administration of quinacrine to tumor-bearing mice.

Authors:  J W VASSEY; J EDMONDS; J L IRVIN; J A GREEN; E M IRVIN
Journal:  Cancer Res       Date:  1955-10       Impact factor: 12.701

6.  Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis.

Authors:  G R Jones
Journal:  Thorax       Date:  1969-01       Impact factor: 9.139

7.  Convulsions following intrapleural administration of quinacrine hydrochloride.

Authors:  I Borda; M Krant
Journal:  JAMA       Date:  1967-09-25       Impact factor: 56.272

8.  Quinacrine (Atabrine) in the treatment of neoplastic effusions.

Authors:  M R Dollinger; I H Krakoff; D A Karnofsky
Journal:  Ann Intern Med       Date:  1967-02       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.